Canada's Research-Based Pharmaceutical Companies invested over a billion dollars in research and development (R&D) in 2007 but opportunities exist for further growth, says Rx&D



    SAN DIEGO, CA, June 19 /CNW Telbec/ - Canada's Research-Based
Pharmaceutical Companies President Russell Williams issued the following
statement from BIO 2008 today in reaction to the release of the Patented
Medicine Prices Review Board's (PMPRB) Annual Report on R&D-to-sales ratio in
the pharmaceutical industry.
    "As the global biotechnology community is gathered in San Diego, it is
clear that the competition to attract biopharmaceutical investments is fierce.
The federal government has taken steps to improve its competitiveness through
initiatives such as data protection and the Science and Technology Strategy.
Provincial governments, including Quebec, Ontario, Alberta and B.C., have
shown their commitment in leveraging the potential for biopharmaceutical
investments through initiatives to support pharmaceutical innovation. But
further steps must be taken, namely to ensure patients can access more
innovative medicines through their provincial drug plans and by guaranteeing
stability and predictability in the intellectual property regime.
    "As the manufacturing sector is experiencing severe challenges in Canada,
the biopharmaceutical sector offers potential for further growth. According to
the latest PMPRB report, our members invested 1.18 billion dollars in R&D of
new medicines in 2007, a 25% growth from 2006.
    "Furthermore, innovative medicines and vaccines remain one of the most
cost-effective medical interventions to treat patients. According to a recent
study from the Fraser Institute, brand name medicines in Canada were priced
53% lower than in the U.S. in 2007, while patients here at home were paying
112% more for their generic drugs compared to patients in the U.S."

    Canada's Research-Based Pharmaceutical Companies (Rx&D) is an association
of members dedicated to improving the health of all Canadians. As partner of
the health-care system, our discoveries help eliminate the need for medical
procedures such as surgery, which have a significant impact on patient quality
of life and health-care budgets. Our community represents over 20,000 men and
women working for more than 50 member companies in Canada and is responsible
for generating 100,000 jobs across Canada.




For further information:

For further information: Heather Dunster, Communications, (613)
236-0455, hdunster@canadapharma.org

Organization Profile

Canada's Research-Based Pharmaceutical Companies (Rx&D)

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890